ARCHIVES

Fox Chase Symposium Tro Focus On Year 2000 Goals

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

October 25, 2013

Moses, Earp to lead AACI. Funding opportunities.

September 12, 2003

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996